The QCMD (Quality Control for Molecular Diagnostic) is an external quality assurance programme that helps to monitor and improve quality within clinical laboratories. In response to the COVID-19 outbreak, a SARS-CoV-2 EQA programme has been launched to assess the sensitivity and specificity of assays which are routinely used for molecular detection of SARS-CoV-2 clinically.

In the latest SARS-CoV-2 EQA programme launched in 2021, laboratory using DiagCor’s GenoScreen^TM SARS-CoV-2 qRT-PCR Assay (compatible with DiagCor's DiagPuro^TM Nucleic Acid Extraction System and Genesis 96Q Real-time PCR System) has participated and attained fully proficient (100% Proficient; Highly satisfactory scores) status. SARS-CoV-2 variants (B.1.1298 & B.1.1.25) and samples with low copy number (2 dPCR Log10 copies/ml) were being successfully detected. DiagCor Life Science prioritizes high product quality and actively supports SARS-CoV-2 testing services in laboratories worldwide, thus contributing to fight against COVID-19.

Read more about GenoScreen^TM SARS-CoV-2 qRT-PCR Assay here, and please get in touch to learn more.